RPS6KB1 and lipoma: Indeed, in lipoma cells, the growth-inhibitory effects of sirolimus are improved when combined with resveratrol, which targets p70S6K (Leipert et al., 2016; Schmid et al., 2014; Wang et al., 2007), suggesting that combined therapies may also improve the efficacy of rapamycin in treating retinal hamartomas.